APP and Alzheimer disease: This theory proposes that the accumulation of a toxic form of Aβ, through abnormal cleavage of the precursor molecule APP [34] and/or reduced clearance [35], leads to the downstream aggregation of tau and cell death, thus precipitating neurodegeneration in AD.